首页> 美国卫生研究院文献>Saudi Pharmaceutical Journal : SPJ >Development and characterization of methoxy poly(ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) micelles as vehicles for the solubilization and delivery of tacrolimus
【2h】

Development and characterization of methoxy poly(ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) micelles as vehicles for the solubilization and delivery of tacrolimus

机译:甲氧基聚(环氧乙烷)-嵌段-聚(ε-己内酯)(PEO-b-PCL)胶束的开发和表征作为他克莫司的增溶和递送载体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tacrolimus is a potent immunosuppressant; however, it suffers from several problems such as poor water solubility (4–12 μg/mL), low and variable oral bioavailability in patients, and narrow therapeutic window that could not be solved by the currently available i.v. formulation (Prograf®). Moreover, Prograf® contains HCO-60 (PEGylated castor oil) as a surfactant, which is reported to cause several side effects including hypersensitivity reactions. Therefore, the aim of the present study was to investigate the potential of PEO-b-PCL polymeric micelles as alternative vehicles for the solubilization and delivery of tacrolimus. Four PEO-b-PCL block copolymers, with different molecular weights of PCL, were synthesized by ring opening polymerization of ε-caprolactone using methoxy polyethylene oxide (5,000 g mol−1) as initiator and stannous octoate as catalyst. Synthesized copolymers were characterized for their average molecular weights and polydispersity index by 1H NMR and gel permeation chromatography (GPC), respectively. Drug-free micelles of PEO-b-PCL were prepared through a co-solvent evaporation method using acetone as the organic co-solvent. Tacrolimus-loaded micelles were prepared using the same method with different initial amounts of drug. Prepared micelles were characterized for their mean diameter size and polydispersity of the micellar population by dynamic light scattering, and an HPLC assay was used to determine the encapsulation efficiency of tacrolimus. The average molecular weights of the synthesized copolymers were in the range of 8,400–28,000 with narrow distributions (PDI = 1.06–1.11). The copolymers were designated according to the degree of polymerization of ε-caprolactone, namely PEO114-b-PCL30, PEO114-b-PCL60, PEO114-b-PCL120, and PEO114-b-PCL200. All the prepared micelles were having diameters sizes less than 100 nm with narrow distributions. The highest drug solubilization was achieved with PEO114-b-PCL120, where the aqueous solubility of tacrolimus exceeded 300 μg/mL. Our results show a potential for PEO-b-PCL micelles as solubilizing vehicles for the delivery of tacrolimus.
机译:他克莫司是一种有效的免疫抑制剂。但是,它存在一些问题,例如水溶性差(4-12μg/ mL),患者口服生物利用度低和可变以及治疗窗口狭窄,目前无法通过静脉注射解决。配方(Prograf®)。此外,Prograf®还包含HCO-60(聚乙二醇蓖麻油)作为表面活性剂,据报道会引起多种副作用,包括超敏反应。因此,本研究的目的是研究PEO-b-PCL聚合物胶束作为他克莫司的增溶和递送的替代载体的潜力。以甲氧基聚环氧乙烷(5,000 g mol -1 )为引发剂,以辛酸亚锡为引发剂,通过ε-己内酯的开环聚合反应合成了四种具有不同分子量的PCO-b-PCL嵌段共聚物。催化剂。分别通过 1 1 H NMR和凝胶渗透色谱(GPC)对合成共聚物的平均分子量和多分散指数进行了表征。 PEO-b-PCL的无毒胶束是通过使用丙酮作为有机助溶剂的共溶剂蒸发法制备的。使用相同的方法使用不同的初始药物量制备了他克莫司负载的胶束。通过动态光散射对制备的胶束的平均直径大小和胶束群体的多分散性进行了表征,并使用HPLC测定了他克莫司的包封效率。合成共聚物的平均分子量为8,400–28,000,分布较窄(PDI = 1.06–1.11)。根据ε-己内酯的聚合度指定共聚物,即PEO114-b-PCL30,PEO114-b-PCL60,PEO114-b-PCL120和PEO114-b-PCL200。所有制备的胶束的直径均小于100 nm,分布较窄。用PEO114-b-PCL120可获得最高的药物溶解度,他克莫司的水溶性超过300μg/ mL。我们的结果表明,PEO-b-PCL胶束作为他克莫司的增溶载体的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号